Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

Clinical trial NCT02486354 · COMPLETED

Trial details

NCT number: NCT02486354
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2010-03-01
Primary completion: 2011-10-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.